Abstract
Consistent chromosome abnormalities have been described in many pediatric solid tumors. These findings led to direct molecular investigation and a better understanding of tumor pathogenesis. Clinical correlation often produced useful prognostic information (Karnes et al. 1992).
References
Aerts, I., Lumbroso-Le Rouic, L., Gauthier-Villars, M., et al. (2006). Retinoblastoma. Orphanet Journal of Rare Diseases, 1, 31–41.
Albertson, D. G., Collins, C., McCormick, F., et al. (2003). Chromosome aberrations in solid tumors. Nature Genetics, 34, 369–376.
Barcus, M. E., Ferreira-Gonzalez, A., Buller, A. M., et al. (2000). Genetic changes in solid tumors. Seminars in Surgical Oncology, 18, 358–370.
Barros, J. E. X. S., Soares-Ventura, D. M., Santos, N., et al. (2012). New cytogenetic aberrations found in a case of aggressive retinoblastoma. Genetics and Molecular Research, 11, 1666–1670.
Bennicelli, J. L., & Barr, F. G. (1999). Genetics and the biologic basis of sarcomas. Current Opinion in Oncology, 11, 267–274.
Betts, D. R., Cohen, N., Leibundgut, K. E., et al. (2005). Characterization of karyotypic events and evolution in neuroblastoma. Pediatric Blood Cancer, 44, 147–157.
Brodeur, G. M., Maris, J. M., Yamashiro, D. J., et al. (1997). Biology and genetics of human neuroblastomas. Journal of Pediatric Hematology/Oncology, 19, 93–101.
Carlson, E. A., & Desnick, R. J. (1979). Mutational mosaicism and genetic counseling in retinoblastoma. American Journal of Medical Genetics, 4, 365–381.
Castel, V., Grau, E., Noguera, R., et al. (2007). Molecular biology of neuroblastoma. Clinical and Translational Oncology, 9, 478–483.
Chen, X., Pappo, A., & Dyer, M. (2015). Pediatric solid tumor genomics and developmental pliancy. Oncogene, 34, 5207–5215.
Chintagumpala, M., Chevez-Barrios, P., Paysse, E. A., et al. (2007). Retinoblastoma: Review of current management. The Oncologist, 12, 1237–1246.
Cooley, L. D., Mascarello, J. T., Hirsch, B., et al. (2009). Section E6.5 of the ACMG technical standards and guidelines: Chromosome studies for solid tumor abnormalities. Genetics in Medicine, 11, 890–897.
Cooper, C. S. (1996). Translocations in solid tumours. Current Opinion in Genetics and Development, 6, 71–75.
Coppes, M. J., & Egeler, R. M. (1999). Genetics of Wilms tumor. Seminars in Urologic Oncology, 17, 2–10.
Davidoff, A. M., & Hill, D. A. (2001). Molecular genetic aspects of solid tumors in childhood. Seminars in Pediatric Surgery, 10, 106–118.
Devesa, S. S. (1975). The incidence of retinoblastoma. American Journal of Ophthalmology, 80, 263–265.
Dougherty, M. J., Tooke, L. S., Sullivan, L. M., et al. (2012). Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors. Cancer Genetics, 205, 42–54.
Draper, G. J., Sanders, B. M., Brownbill, P. A., et al. (1992). Patterns of risk of hereditary retinoblastoma and applications to genetic counseling. British Journal of Cancer, 66, 211–219.
Esparza, S. D. (2012). Childhood cancer, genetics. eMedicine from WebMD. Updated March 5, 2012. Available at: http://emedicine.medscape.com/article/989983-overview
Horsthemke, B. (1992). Genetics and cytogenetics of retinoblastoma. Cancer Genetics and Cytogenetics, 63, 1–7.
İnandıklıoğlu, N., Yılmaz, S., Demirhan, O., et al. (2012). Chromosome imbalances and alterations of AURKA and MYCN genes in children with neuroblastoma. Asian Pacific Journal of Cancer Prevention, 13, 5391–5397.
Isidro, M. A., Roque, M. R., Aaberg, T. M. J., et al. (2011). Retinoblastoma. Medscape Reference. Updated 29 April 2011. Available at: http://emedicine.medscape.com/article/1222849-overview
Karnes, P. S., Tran, T. N., Cui, M. Y., et al. (1992). Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genetics and Cytogenetics, 59, 12–19.
Kesrouani, A., Duchatel, F., Seilanian, M., et al. (1999). Prenatal diagnosis of adrenal neuroblastoma by ultrasound: A report of two cases and review of the literature. Ultrasound in Obstetrics & Gynecology, 13, 446–449.
Knudson, A. G. (1971). Mutation and cancer: Statistical study of retinoblastoma. Proceedings of National Academy Science USA, 68, 82–823.
Lee, K. L., Ma, J. F., & Shortliffe, L. D. (2003). Neuroblastoma: Management, recurrence, and follow-up. Urologic Clinics of North America, 30, 881. http://emedicine.medscape.com/article/988284-overview
Lohmann, D. R., & Gallie, B. L. (2013). Retinoblastoma. GeneReviews. Updated March 28, 2013. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1452/
Maris, J. M., & Matthay, K. K. (1999). Molecular biology of neuroblastoma. Journal of Clinical Oncology, 17, 2264–2279.
Mertens, F., Mandahl, N., Mitelman, F., et al. (1994). Cytogenetic analysis in the examination of solid tumors in children. Pediatric Hematology and Oncology, 11, 361–377.
Paxton, C. N., Rowe, L. R., & South, S. T. (2015). Observations of the genomic landscape beyond 1p19q deletions and EGFR amplification in glioma. Molecular Cytogenetics, 8, 60–66.
Paulino, A. C. (2014). Wilms tumor. eMedicine from WebMD. Retrieved November 8, 2014. Available at: http://emedicine.medscape.com/article/989398-overview
Sandberg, A. A. (1988). Chromosomal lesions and solid tumors. Hospital Practice October, 15, 93–106.
Sandberg, A. A., & Turc-Carel, C. (1987). The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology. Cancer, 59, 387–395.
Schwab, M., Westermann, F., Hero, B., et al. (2003). Neuroblastoma: Biology and molecular and chromosomal pathology. The Lancet Oncology, 4, 472–480.
Sippel, K. C., Faioli, R. E., Smith, G. D., et al. (1998). Frequency of somatic and germ-line mosaicism in retinoblastoma: Implications for genetic counseling. American Journal of Human Genetics, 62, 610–619.
Tien, J. D. Y., Lau, L. C., Tien, S. L., et al. (2014). The clinical utility of conventional karyotyping in the detection of cytogenetic abnormalities in soft tissue tumours: An Asian institutional experience. Hong Kong Medical Journal, 20, 393–400.
Vadeyar, S., Ramsay, M., James, D., et al. (2000). Prenatal diagnosis of congenital Wilms’ tumor (nephroblastoma) presenting as fetal hydrops. Ultrasound in Obstetrics & Gynecology, 16, 80–83.
Varella-Garcia, M. (2003). Molecular cytogenetics in solid tumors: Laboratorial tool for diagnosis, prognosis, and therapy. The Oncologist, 8, 45–58.
Vogel, F. (1979). Genetics of retinoblastoma. Human Genetics, 1, 1–54.
Zin, R., Pham, K., Ashleigh, M., et al. (2012). SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms’ tumor. Cancer Genetics, 205, 80–93.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2017). Chromosome Abnormalities in Pediatric Solid Tumors. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_42
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2401-1_42
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2400-4
Online ISBN: 978-1-4939-2401-1
eBook Packages: MedicineReference Module Medicine